Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct 26:10:512090.
doi: 10.3389/fcimb.2020.512090. eCollection 2020.

Francisella tularensis, Tularemia and Serological Diagnosis

Affiliations
Review

Francisella tularensis, Tularemia and Serological Diagnosis

Max Maurin. Front Cell Infect Microbiol. .

Abstract

Tularemia is a zoonotic disease caused by the bacterium Francisella tularensis. The predominant sources, routes of infection, and clinical manifestations of human infections greatly vary according to the geographic area considered. Moreover, clinical suspicion of tularemia is often tricky because of the lack of specificity of the clinical manifestations. Because F. tularensis isolation is tedious and detection of its DNA usually requires removal of infected tissues, serological techniques are most often used for diagnostic confirmation. However, these techniques are varied and poorly standardized. The microagglutination test (MAT), the indirect immunofluorescence assay (IFA), and ELISA tests are currently the most frequently used techniques. These home-made and commercial tests are mainly used for tularemia diagnosis but also seroprevalence studies. ELISA tests detect specific antibodies within two weeks of disease evaluation, compared to 2-3 weeks for MAT and IFA. However, more false-positive results are usually reported with ELISA. The long-term persistence of anti-F. tularensis antibodies in patients with past tularemia infection hampers the diagnostic specificity of all these tests. Also, cross-reacting antibodies have been described (especially with Brucella and Yersinia species), although usually at a low level. The immunoblotting technique can highlight these serological cross-reactions. Tularemia remains an underdiagnosed disease in most endemic areas, and the clinical presentations of this disease are evolving. It is necessary to improve further speed and accuracy of tularemia diagnosis, as well as the standardization of diagnostic procedures.

Keywords: Francisella tularensis; diagnosis; serological diagnosis; serological methods; tularemia.

PubMed Disclaimer

References

    1. Akhvlediani N., Burjanadze I., Baliashvili D., Tushishvili T., Broladze M., Navdarashvili A., et al. (2018). Tularemia transmission to humans: a multifaceted surveillance approach. Epidemiol. Infect. 146, 2139–2145. 10.1017/S0950268818002492 - DOI - PMC - PubMed
    1. Aravena-Román M., Merritt A., Inglis T. J. J. (2015). First case of Francisella bacteraemia in Western Australia. New Microbes New Infect. 8, 75–77. 10.1016/j.nmni.2015.10.004 - DOI - PMC - PubMed
    1. Ata N., Kılıç S., Ovet G., Alataş N., Celebi B. (2013). Tularemia during pregnancy. Infection 41, 753–756. 10.1007/s15010-013-0456-5 - DOI - PubMed
    1. Behan K. A., Klein G. C. (1982). Reduction of Brucella species and Francisella tularensis cross-reacting agglutinins by dithiothreitol. J. Clin. Microbiol. 16, 756–757. 10.1128/JCM.16.4.756-757.1982 - DOI - PMC - PubMed
    1. Bevanger L., Maeland J. A., Naess A., II (1988). Agglutinins and antibodies to Francisella tularensis outer membrane antigens in the early diagnosis of disease during an outbreak of tularemia. J. Clin. Microbiol. 26, 433–437. 10.1128/JCM.26.3.433-437.1988 - DOI - PMC - PubMed

Publication types

Substances